发明名称 TREATMENT OF ALZHEIMER'S DISEASE WITH INHIBITORS OF APOE BINDING TO APOE RECEPTOR
摘要 Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta peptide (Abeta) in the brain. Abeta is derived from amyloid precursor protein (APP) by beta- and gamma-secretases. Apolipoprotein E receptor 2 (ApoER2) is a cell-surface receptor for apolipoprotein E. This study shows that ApoER2 interacts with X11alpha/beta proteins and that APP forms association with ApoER2 in the presence of X11s. Significantly, ApoE stimulates the production of Abeta, and ApoE4 produced more Abeta than ApoE2 or ApoE3, correlating with previous studies showing that individuals with the ApoE4 polymorphism were more prone to development of AD. Thus, ApoE binding to ApoER2 on cell surface stimulates the generation of Abeta from APP. Antagonists that interfere with the ApoE-ApoER2 interaction are proposed for the treatment of AD.
申请公布号 US2007248599(A1) 申请公布日期 2007.10.25
申请号 US20070676042 申请日期 2007.02.16
申请人 TANG JORDAN 发明人 TANG JORDAN
分类号 A61K39/395;A61K31/7052;A61K48/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址